Skip to main content

Table 4 Univariate analysis of DFS among patients with stage I OEC

From: Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma

Variable Category N(%) DFS(Median(IQR)) DFS rate(%) P
Age y <50 45 (57.7%) 75.0 (54.0,102.0) 86.7% 0.2563
  > = 50 33 (42.3%) 56.0 (30.0,81.0) 75.76  
Menopausal status Pre 47 (60.3%) 82.0 (44.0,109.0) 82.98 0.0526
  Post 31 (39.7%) 56.0 (25.0,78.0) 70.97  
Gravidity 0 12 (15.38) 106.5 (63,143) 83.33 0.2028
  > = 1 66 (84.62) 65.5 (36,90) 77.27  
Parity 0 18 (23.08) 85 (63,131) 83.33 0.1870
  > = 1 60 (76.92) 65 (35,94) 76.67  
CA125 normal Yes 9 (11.5%) 70 (65 ~ 102) 88.89 0.3948
  No 69 (88.5%) 67 (34 ~ 98) 76.81  
Hypertension Yes 11 (14.1%) 57 (12 ~ 81) 81.82 0.8304
  No 67 (85.90%) 70 (38 ~ 102) 77.61  
Tumor side Unilateral 63 (80.77%) 67 (30 ~ 101) 76.19 0.4040
  Bilateral 15 (19.23%) 71 (38 ~ 102) 86.67  
Tumor size <10 45 (57.69%) 75 (44 ~ 102) 77.78 0.4971
  ≥10 33 (42.31%) 56 (16 ~ 84) 78.79  
Endometriosis Yes 23 (29.5%) 66 (36 ~ 90) 86.96 0.3539
  No 55 (70.5%) 69 (34 ~ 102) 74.55  
Endometrial disorders Yes 21 (26.9%) 65 (12 ~ 102) 85.71 0.2406
  No 57 (73.1%) 68 (38 ~ 98) 75.44  
Stage IA + IB 26 (33.3%) 67.0 (39.0,109.0) 88.46 0.0583
  IC 52 (66.7%) 67.5 (29.5,99.5) 73.08  
Mixed histology No 73 (93.59) 69 (36,102) 79.45 0.1295
  Yes 5 (6.419) 38 (36,65) 60  
Grade G1 35 (44.8%) 82 (59, 117) 85.71 0.0008*
  G2 26 (33.3%) 64 (29, 98) 84.62  
  G3 17 (21.8%) 39 (28, 66) 52.94  
Cytology of ascites Negative 70 (89.74) 68.5 [36,101] 81.43 0.0253*
  Positive 8 (10.26) 61.5 [21.5,89.5] 50  
ER Negative 12 (32.43) 73 [47,102] 83.33 0.7491
  Positive 25 (67.57) 66 [44,86] 80  
PR Negative 8 (21.62) 68 [49.5,88.5] 87.5 0.6476
  Positive 29 (78.38) 67 [44,90] 79.31  
Lymphadenectomy Yes 71 (91.0%) 68 (36,102) 81.69 0.0041*
  No 7 (9.0%) 38 (9, 101) 42.86  
Para-aotic Lymphadenectomy No 27 (37.5) 71 [44,131] 77.78 0.8075
  Yes 45 (62.5) 63 [30,90] 82.22  
Numbers of dissected Lymphadenectomy <17 34 (43.59) 72.5 [39,131] 76.47 0.8693
  > = 17 38 (48.72) 64 [29,84] 84.21  
Chemotherapygroup <4 21 (30.9%) 82 (62–121.5) 90.50 0.056
  ≥4 47 (69.1%) 65 (30 ~ 101) 72.34  
  1. P values were cultivated by Kaplan-Meier analysis